Sabu Pharma SRL
Sabu Pharma reported total assets of 520,028 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of Sabu Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sabu Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 16,544 € |
| Equity | 19,544 € |
| Cash | 15,218 € |
| EBITDA | 37,671 € |
| Total assets | 520,028 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
Sabu Pharma's financial analysis
- Solvency3.8%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sabu Pharma
Sabu Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1021.744.847
- VAT number
- BE1021744847
- Peppol
- Registered · 0208:1021744847 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Apr 2025
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Sabu Pharma (SRL) has been based in Antwerp since 2025, active in: activities of holding companies. For 2025, it reports a net profit of 16,544 € and equity of 19,544 €; its revenue is not published. Its solvency stands at 3.8%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sabu Pharma
Companies in the same business, of comparable size and area, outside its group.
- MaKiMi Consulting Activities of holding companies Nazareth-De Pinte · balance sheet 766,771 €
- NOMA'S Ventures Activities of holding companies Wervik · balance sheet 112,657 €
- MJ Pharma Activities of holding companies Vorselaar · balance sheet 534,747 €
- AVP Consult Activities of holding companies Lichtervelde · balance sheet 602,890 €
- Bawser Activities of holding companies Niel · balance sheet 629,403 €
- Win Asset Management Activities of holding companies Antwerp · balance sheet 486,895 €
- LTC&I Activities of holding companies Sint-Martens-Latem · balance sheet 508,766 €
- LCON Activities of holding companies Jabbeke · balance sheet 383,498 €
Frequently asked questions about Sabu Pharma
What is the revenue of Sabu Pharma?
Sabu Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sabu Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1021744847 for Sabu Pharma, if the company is VAT-registered. Its company number (CBE) is 1021.744.847.
Where is the registered office of Sabu Pharma?
According to the CBE register, the registered office of Sabu Pharma is in 2610 Antwerp.
What is the equity of Sabu Pharma?
At the close of the 2025 financial year, the equity of Sabu Pharma amounts to 19,544 €, a solvency of 3.8% of total assets.
Who manages Sabu Pharma?
The register lists 1 active mandates at Sabu Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sabu Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →